How does the PCT benefit cancer research and innovation?
The PCT offers several advantages for cancer research and innovation:
Cost Efficiency: Filing a single international application is generally more cost-effective than filing separate applications in each country. Extended Time: It provides up to 30 months from the initial filing date to enter national phases, giving more time for research and development. International Recognition: Innovations related to cancer can receive broader recognition and protection, facilitating international collaboration.
